4-Cyano-4-phenylpiperidine hydrochloride

• Catalog No.: C94408
• CAS Number: 51304-58-6
• M. F.: C12H15ClN2
• M. W.: 222.7139
• Purity: 97%

SYNONYMS

• Title: 4-氰基-4-苯基哌嗪 盐酸盐
• IUPAC name: 4-phenylpiperidine-4-carbonitrile hydrochloride
• IUPAC Traditional name: 4-phenylpiperidine-4-carbonitrile hydrochloride
• Synonyms: 4-苯基-4-哌啶腈 盐酸盐; 4-Phenyl-4-piperidinecarbonitrile hydrochloride

DATABASE IDS

• CAS Number: 51304-58-6
• PubChem SID: 24892998
• EC Number: 257-124-5
• MDL Number: MFCD00012775

PROPERTIES

• Empirical Formula (Hill Notation): C12H14N2 · HCl
• Purity: 97%
• Melting Point: 208-210 °C(lit.)
• GHS Signal Word: Warning
• GHS Hazard statements: H302-H312-H315-H319-H332-H335
• European Hazard Symbols: Harmful (Xn)
• Personal Protective Equipment: dust mask type N95 (US), Eyeshields, Gloves
• GHS Precautionary statements: P261-P280-P305 + P351 + P338
• Risk Statements: 20/21/22-36/37/38
• Safety Statements: 26-36/37/39
• German water hazard class: 3

DETAILS

Description (English)

Packaging
1 g in glass bottle
10 g in poly bottle
Application
Reactant for synthesis of:
• CCR5 antagonists derived at the N-terminal of the piperidine ring1
• Substituted piperidines as lignads of chemokine receptor 5 and inhibitors of HIV-12
• Functionalized nitrogen heterocycles by radical decarboxylation of β- and γ- amino acids3
• Benzovesamicol analogs as potential imaging probes for vesicular acetylcholine transporters4
• Neurotransmitter transporter inhibitors with activity at dopamine receptor sites5
• α1a Adrenoceptor-selective antagonists6

Description (简体中文)

包装
1 g in glass bottle
10 g in poly bottle
Application
Reactant for synthesis of:
• CCR5 antagonists derived at the N-terminal of the piperidine ring1
• Substituted piperidines as lignads of chemokine receptor 5 and inhibitors of HIV-12
• Functionalized nitrogen heterocycles by radical decarboxylation of β- and γ- amino acids3
• Benzovesamicol analogs as potential imaging probes for vesicular acetylcholine transporters4
• Neurotransmitter transporter inhibitors with activity at dopamine receptor sites5
• α1a Adrenoceptor-selective antagonists6